Dominik Niopek
Dominik Niopek
Verified email at
Cited by
Cited by
CRISPR/Cas9‐mediated genome engineering: an adeno‐associated viral (AAV) vector toolbox
E Senís, C Fatouros, S Große, E Wiedtke, D Niopek, AK Mueller, K Börner, ...
Biotechnology journal 9 (11), 1402-1412, 2014
Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells
D Niopek, D Benzinger, J Roensch, T Draebing, P Wehler, R Eils, ...
Nature communications 5 (1), 1-11, 2014
Optogenetic control of nuclear protein export
D Niopek, P Wehler, J Roensch, R Eils, B Di Ventura
Nature communications 7 (1), 1-9, 2016
Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9
F Bubeck, MD Hoffmann, Z Harteveld, S Aschenbrenner, A Bietz, ...
Nature methods 15 (11), 924-927, 2018
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines
K Börner, D Niopek, G Cotugno, M Kaldenbach, T Pankert, J Willemsen, ...
Nucleic acids research 41 (21), e199-e199, 2013
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
MD Hoffmann, S Aschenbrenner, S Grosse, K Rapti, C Domenger, ...
Nucleic acids research 47 (13), e75-e75, 2019
Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling
E Kienle, E Senís, K Börner, D Niopek, E Wiedtke, S Grosse, D Grimm
JoVE (Journal of Visualized Experiments), e3819, 2012
Creating functional engineered variants of the single-module non-ribosomal peptide synthetase IndC by T domain exchange
R Beer, K Herbst, N Ignatiadis, I Kats, L Adlung, H Meyer, D Niopek, ...
Molecular BioSystems 10 (7), 1709-1718, 2014
Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity
S Aschenbrenner, SM Kallenberger, MD Hoffmann, A Huck, R Eils, ...
Science advances 6 (6), eaay0187, 2020
A robust and all-inclusive pipeline for shuffling of adeno-associated viruses
AK Herrmann, C Bender, E Kienle, S Grosse, J El Andari, J Botta, ...
ACS synthetic biology 8 (1), 194-206, 2018
AAV vector-mediated in vivo reprogramming into pluripotency
E Senís, L Mosteiro, S Wilkening, E Wiedtke, A Nowrouzi, S Afzal, ...
Nature communications 9 (1), 1-14, 2018
Are artists and engineers inventing the culture of tomorrow?
U Damm, B Hopfengärtner, D Niopek, P Bayer
Futures 48, 55-64, 2013
Optogenetic control of nuclear protein import in living cells using light‐inducible nuclear localization signals (LINuS)
P Wehler, D Niopek, R Eils, B Di Ventura
Current protocols in chemical biology 8 (2), 131-145, 2016
Leveraging implicit knowledge in neural networks for functional dissection and engineering of proteins
JU zu Belzen, T Bürgel, S Holderbach, F Bubeck, L Adam, C Gandor, ...
Nature Machine Intelligence 1 (5), 225-235, 2019
Controlling cells with light and LOV
MD Hoffmann, F Bubeck, R Eils, D Niopek
Advanced Biosystems 2 (9), 1800098, 2018
Computational design of anti-CRISPR proteins with improved inhibition potency
J Mathony, Z Harteveld, C Schmelas, JU Zu Belzen, S Aschenbrenner, ...
Nature chemical biology 16 (7), 725-730, 2020
A hepatic GAbp-AMPK axis links inflammatory signaling to systemic vascular damage
K Niopek, BE Üstünel, S Seitz, M Sakurai, A Zota, F Mattijssen, X Wang, ...
Cell reports 20 (6), 1422-1434, 2017
Use of bacteria for the sensing and killing of cancer cells
R Eils, P Hundeshagen, Y Reis, D Richter, J Keienburg, M Reichenzeller, ...
US Patent App. 13/125,945, 2011
To go, or not to go, that is the question–Six personal reflections on how geographic mobility may affect your career and life
D Niopek, R Berrens, S Mockenhaupt, MD Lewis, AK Mueller, D Grimm
Bioessays 33 (10), 728-731, 2011
Enlightening Allostery: Designing Switchable Proteins by Photoreceptor Fusion
J Mathony, D Niopek
Advanced Biosystems, 2000181, 2020
The system can't perform the operation now. Try again later.
Articles 1–20